p.114 抽出テキスト

237. Adhyapak SM, Parachuri VR. Architecture of the left ventricle: insights for optimal surgical ventricular restoration. Heart Fail Rev 2010; 15: 73-83. PMID: 19757029 238. Calafiore AM, Iacò AL, Amata D, et al. Left ventricular surgical restoration for anteroseptal scars: volume versus shape. J Thorac Cardiovasc Surg 2010; 139: 1123-1130. PMID: 20412951 239. Jones RH, Velazquez EJ, Michler RE, et al. STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360: 1705-1717. PMID: 19329820 240. Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J Thorac Cardiovasc Surg 2009; 138: 1060-1064.e2. PMID: 19837213 241. Wakasa S, Matsui Y, Kobayashi J, et al. Estimating postoperative left ventricular volume: Identification of responders to surgical ventricular reconstruction. J Thorac Cardiovasc Surg 2018; 156: 2088-2096. e3. PMID: 30195600 242. Suma H, Anyanwu AC. Current status of surgical ventricular restoration for ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg 2012; 24: 294-301. PMID: 23465678 243. Wakasa S, Matsui Y, Isomura T, et al. Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: results of a Japanese multicenter study. J Thorac Cardiovasc Surg 2014; 147: 1868-1874.e2. PMID: 23968870 244. Castelvecchio S, Menicanti L, Ranucci M. Surgical and Clinical Outcome Research (SCORE) Group. Development and validation of a risk score for predicting operative mortality in heart failure patients undergoing surgical ventricular reconstruction. Eur J Cardiothorac Surg 2015; 47: e199-e205. PMID: 25691068 245. Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev 2004; 9: 287-297. PMID: 15886974 246. Di Donato M, Castelvecchio S, Kukulski T, et al. Surgical ventricular restoration: left ventricular shape influence on cardiac function, clinical status, and survival. Ann Thorac Surg 2009; 87: 455-461. PMID: 19161759 247. Wakasa S, Matsui Y, Isomura T, et al. Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience. Interact Cardiovasc Thorac Surg 2013; 16: 785-791. PMID: 23475121 248. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999; 33: 1848- 1854. PMID: 10362184 249. Holly TA, Bonow RO, Arnold JM, et al. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. J Thorac Cardiovasc Surg 2014; 148: 2677-2684.e1. PMID: 25152476 250. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59. PMID: 9671897 251. Isomura T, Horii T, Suma H, et al. RESTORE Group. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not disease. Eur J Cardiothorac Surg 2006; 29 Suppl: S245-S250. PMID: 16567109 252. Matsui Y, Fukada Y, Suto Y, et al. Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg 2002; 124: 395-397. PMID: 12167802 253. Yaku H, Ohira S, Yamazaki S, et al. Endocardial linear infarct exclusion technique for infarcted lateral wall. Interact Cardiovasc Thorac Surg 2017; 24: 460-461. PMID: 28040767 254. Isomura T, Notomi Y, Hoshino J, et al. Indication of posterior restoration and surgical results in patients with dilated cardiomyopathy. Eur J Cardiothorac Surg 2010; 38: 171-175. PMID: 20194031 255. Menicanti L, Castelvecchio S, Ranucci M, et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg 2007; 134: 433- 441. PMID: 17662785 256. 厚生労働省.平成28年国民健康・栄養調査報告. 2017. https:// www.mhlw.go.jp/bunya/kenkou/eiyou/h28-houkoku.html 257. Beckman JA, Paneni F, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 2013; 34: 2444-2452. PMID: 23625211 258. Zellweger MJ, Maraun M, Osterhues HH, et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging 2014; 7: 1001-1010. PMID: 25240454 259. Aronson D, Rayfield EJ. Diabetes and obesity. In: Fuster V, Ross R, Topol EJ, et al. Atherosclerosis and coronary artery disease. Lippincott-Raven 1996: 327-359. 260. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234. PMID: 9673301 261. Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50. PMID: 28437734 262. Gregg EW, Williams DE, Geiss L. Changes in diabetes-related complications in the United States. N Engl J Med 2014; 371: 286-287. PMID: 25014698 263. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-2278. PMID: 15123524 264. Park GM, Lee SW, Park SW, et al. Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIA- BETES II trial. Am J Cardiol 2013; 112: 1565-1570. PMID: 24063840 265. Maeng M, Jensen LO, Tilsted HH, et al. Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy). Am J Cardiol 2011; 108: 1232-1237. PMID: 21864817 266. de Waha A, Stefanini GG, King LA, et al. Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. Int J Cardiol 2013; 168: 5162-5166. PMID: 23993323 267. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-225. PMID: 8657237 268. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122-1129. PMID: 10758950 269. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007; 49: 1600-1606. PMID: 17433949 270. Nagendran J, Bozso SJ, Norris CM, et al. Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction. J Am Coll Cardiol 2018; 71: 819-827. PMID: 29471931 271. Holzmann MJ, Rathsman B, Eliasson B, et al. Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. J Am Coll Cardiol 2015; 65: 1644-1652. PMID: 25908069 272. Minakata K, Bando K, Takanashi S, et al. JMAP Study Investigators. Impact of diabetes mellitus on outcomes in Japanese patients undergoing coronary artery bypass grafting. J Cardiol 2012; 59: 275-284. PMID: 22459591 273. Herlitz J, Wognsen GB, Emanuelsson H, et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996; 19: 698-703. PMID: 8799622 274. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-423. PMID: 12142105 275. Luciani N, Nasso G, Gaudino M, et al. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg 2003; 76: 1149-1154. PMID: 14530003 276. Szabó Z, Håkanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002; 74: 712-719. PMID: 12238829 277. Kubal C, Srinivasan AK, Grayson AD, et al. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005; 79: 1570-1576. PMID: 15854935 278. Wit MA, de Mulder M, Jansen EK, et al. Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery. Acta Diabetol 2013; 50: 123-128. PMID: 20857149 279. Miyazaki S, Yoshitani K, Miura N, et al. Risk factors of stroke and delirium after off-pump coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2011; 12: 379-383. PMID: 21148261 280. Deaton C, Thourani V. Patients with type 2 diabetes undergoing coro-